MA53346A - Composition de vaccin muqueux pour la mastite bovine - Google Patents
Composition de vaccin muqueux pour la mastite bovineInfo
- Publication number
- MA53346A MA53346A MA053346A MA53346A MA53346A MA 53346 A MA53346 A MA 53346A MA 053346 A MA053346 A MA 053346A MA 53346 A MA53346 A MA 53346A MA 53346 A MA53346 A MA 53346A
- Authority
- MA
- Morocco
- Prior art keywords
- mucous
- vaccine composition
- bovine mastitis
- mastitis
- bovine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018147175A JP2020019754A (ja) | 2018-08-03 | 2018-08-03 | ウシ***炎に対する粘膜ワクチン組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA53346A true MA53346A (fr) | 2022-04-27 |
Family
ID=69231804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA053346A MA53346A (fr) | 2018-08-03 | 2019-08-02 | Composition de vaccin muqueux pour la mastite bovine |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210322531A1 (fr) |
EP (1) | EP3831405A4 (fr) |
JP (1) | JP2020019754A (fr) |
CN (1) | CN112533631A (fr) |
MA (1) | MA53346A (fr) |
WO (1) | WO2020027318A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2022248775A1 (en) * | 2021-03-30 | 2023-10-12 | Hanavax Inc. | Nanogel-coated vaccine |
CN114306237A (zh) * | 2022-01-06 | 2022-04-12 | 江苏爱朋医疗科技股份有限公司 | 一种鼻腔护理喷雾剂及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100541752B1 (ko) | 1998-08-31 | 2006-01-10 | 니혼유시 가부시기가이샤 | 고순도 소수성기함유다당류 및 그 제조방법 |
JP2009286730A (ja) | 2008-05-29 | 2009-12-10 | Nai Kk | 新規***炎ワクチン |
JP5344558B2 (ja) * | 2008-10-31 | 2013-11-20 | 国立大学法人 東京医科歯科大学 | カチオン性ナノゲルを用いる粘膜ワクチン |
WO2014054588A1 (fr) | 2012-10-01 | 2014-04-10 | 国立大学法人京都大学 | Complexe nanogel-exosome et mode d'administration |
JP6310720B2 (ja) * | 2014-02-17 | 2018-04-11 | 知的財産戦略ネットワーク株式会社 | 肺炎球菌経鼻ワクチン |
-
2018
- 2018-08-03 JP JP2018147175A patent/JP2020019754A/ja active Pending
-
2019
- 2019-08-02 CN CN201980051500.9A patent/CN112533631A/zh active Pending
- 2019-08-02 US US17/265,020 patent/US20210322531A1/en not_active Abandoned
- 2019-08-02 WO PCT/JP2019/030451 patent/WO2020027318A1/fr unknown
- 2019-08-02 EP EP19844097.6A patent/EP3831405A4/fr not_active Withdrawn
- 2019-08-02 MA MA053346A patent/MA53346A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CN112533631A (zh) | 2021-03-19 |
US20210322531A1 (en) | 2021-10-21 |
WO2020027318A1 (fr) | 2020-02-06 |
EP3831405A1 (fr) | 2021-06-09 |
EP3831405A4 (fr) | 2022-04-27 |
JP2020019754A (ja) | 2020-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54714A (fr) | Formulation de nicotine | |
MA53544A (fr) | Procédé de préparation de compositions de vaccin | |
EA201891489A1 (ru) | Фармацевтическая композиция, содержащая аморфный леналидомид и антиоксидант | |
SG11202010821TA (en) | Vaccine composition | |
MA43587A (fr) | Arnm thérapeutiques codant pour des anticorps anti-ctla-4 | |
ES2974693T3 (es) | Sistema de implante dental mejorado | |
FR3027521B1 (fr) | Compositions pour administration par voie orale | |
MA43800A (fr) | Octréotide par voie orale pour le traitement de maladies | |
GB201802339D0 (en) | Immunogenic composition | |
DK3873362T3 (da) | Kirurgisk indretning til implantatfjernelse | |
MA53346A (fr) | Composition de vaccin muqueux pour la mastite bovine | |
SG11202009147UA (en) | Vaccine compositions | |
DK3274447T3 (da) | Rekombinant fåresygevirus jeryl lynn 2 baseret vaccine | |
IL282753A (en) | Immunogenic compounds | |
IL283802A (en) | Protein preparations with a high concentration to prevent tissue adhesion | |
PT3632436T (pt) | Composição farmacêutica compreendendo sais de lenvatinib | |
MA53131A (fr) | Composition immunogène pour la paratuberculose | |
DK3908321T3 (da) | Farmaceutisk sammensætning | |
DK3773501T3 (da) | Intravaginal formulering | |
DK3781132T3 (da) | Apixabanformuleringer | |
DK3763212T3 (da) | Artropoda-afvisende sammensætning | |
DK3752598T3 (da) | Allogen sammensætning | |
MA51826A (fr) | Compositions pharmaceutiques comprenant de la teixobactine | |
EP3766979A4 (fr) | Plateforme de vaccin antigrippal vivant multivalent utilisant un adénovirus recombinant | |
GB201803692D0 (en) | Immunogenic composition |